RE:💥Galleri, with a low false positive rate of less than 1%You know who you are. Keep posting out of desparation.
Galleri won't be ready for commercialization for still another few years to come, if ever. Meanwhile, StageZero could add more cancer detections as it further develops Aristotle. We can call it upgrades to Aristotle going forward.
Spamming your nonsense to bash Aristotle won't change the fact that it will be released very soon in the market and will be the first of it's kind.